• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

围生期心肌病的病理生理学和危险因素。

Pathophysiology and risk factors of peripartum cardiomyopathy.

机构信息

Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.

Department of Medicine, Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

出版信息

Nat Rev Cardiol. 2022 Aug;19(8):555-565. doi: 10.1038/s41569-021-00664-8. Epub 2022 Jan 11.

DOI:10.1038/s41569-021-00664-8
PMID:35017720
Abstract

Peripartum cardiomyopathy (PPCM) is a potentially fatal form of idiopathic heart failure with variable prevalence across different countries and ethnic groups. The cause of PPCM is unclear, but environmental and genetic factors and pregnancy-associated conditions such as pre-eclampsia can contribute to the development of PPCM. Furthermore, animal studies have shown that impaired vascular and metabolic function might be central to the development of PPCM. A better understanding of the pathogenic mechanisms involved in the development of PPCM is necessary to establish new therapies that can improve the outcomes of patients with PPCM. Pregnancy hormones tightly regulate a plethora of maternal adaptive responses, including haemodynamic, structural and metabolic changes in the cardiovascular system. In patients with PPCM, the peripartum period is associated with profound and rapid hormonal fluctuations that result in a brief period of disrupted cardiovascular (metabolic) homeostasis prone to secondary perturbations. In this Review, we discuss the latest studies on the potential pathophysiological mechanisms of and risk factors for PPCM, with a focus on maternal cardiovascular changes associated with pregnancy. We provide an updated framework to further our understanding of PPCM pathogenesis, which might lead to an improvement in disease definition.

摘要

围生期心肌病(PPCM)是一种潜在致命的特发性心力衰竭,在不同国家和种族中的发病率不同。PPCM 的病因尚不清楚,但环境和遗传因素以及与妊娠相关的疾病,如子痫前期,可能会导致 PPCM 的发生。此外,动物研究表明,血管和代谢功能受损可能是 PPCM 发生的核心机制。为了建立能够改善 PPCM 患者预后的新疗法,有必要深入了解 PPCM 发病机制中涉及的致病机制。妊娠激素可严密调控多种母体适应性反应,包括心血管系统的血液动力学、结构和代谢变化。在 PPCM 患者中,围生期与深刻而快速的激素波动有关,导致短暂的心血管(代谢)稳态破坏,容易发生继发性紊乱。在这篇综述中,我们讨论了 PPCM 的潜在病理生理机制和危险因素的最新研究进展,重点关注与妊娠相关的母体心血管变化。我们提供了一个更新的框架,以进一步了解 PPCM 的发病机制,这可能会改善疾病的定义。

相似文献

1
Pathophysiology and risk factors of peripartum cardiomyopathy.围生期心肌病的病理生理学和危险因素。
Nat Rev Cardiol. 2022 Aug;19(8):555-565. doi: 10.1038/s41569-021-00664-8. Epub 2022 Jan 11.
2
Peripartum cardiomyopathy: basic mechanisms and hope for new therapies.围生期心肌病:基本机制和新疗法的希望。
Cardiovasc Res. 2020 Mar 1;116(3):520-531. doi: 10.1093/cvr/cvz252.
3
Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy.围生期心肌病的病理生理学、诊断和治疗:欧洲心脏病学会心力衰竭协会围生期心肌病研究组的立场声明。
Eur J Heart Fail. 2019 Jul;21(7):827-843. doi: 10.1002/ejhf.1493. Epub 2019 Jun 27.
4
Peripartum cardiomyopathy in low- and middle-income countries.中低收入国家的围生期心肌病。
Best Pract Res Clin Obstet Gynaecol. 2024 Mar;93:102476. doi: 10.1016/j.bpobgyn.2024.102476. Epub 2024 Feb 17.
5
EURObservational Research Programme: a worldwide registry on peripartum cardiomyopathy (PPCM) in conjunction with the Heart Failure Association of the European Society of Cardiology Working Group on PPCM.EURObservational Research Programme:一项关于围产期心肌病(PPCM)的全球性注册研究,与欧洲心脏病学会心力衰竭协会的 PPCM 工作组合作。
Eur J Heart Fail. 2014 May;16(5):583-91. doi: 10.1002/ejhf.68. Epub 2014 Mar 3.
6
Understanding Peripartum Cardiomyopathy.了解围产期心肌病。
Annu Rev Med. 2018 Jan 29;69:165-176. doi: 10.1146/annurev-med-041316-090545. Epub 2017 Aug 16.
7
Peripartum Cardiomyopathy: Current Understanding of Pathophysiology, Diagnostic Workup, Management, and Outcomes.围生期心肌病:病理生理学、诊断方法、治疗和结局的最新认识。
Curr Probl Cardiol. 2023 Aug;48(8):101716. doi: 10.1016/j.cpcardiol.2023.101716. Epub 2023 Mar 25.
8
Incidence, Risk Factors, Maternal and Neonatal Outcomes of Peripartum Cardiomyopathy (PPCM) in Oman.阿曼围生期心肌病(PPCM)的发病率、危险因素、母婴结局。
Glob Heart. 2023 May 2;18(1):23. doi: 10.5334/gh.1198. eCollection 2023.
9
Incident stroke in individuals with peripartum cardiomyopathy.围生期心肌病患者的卒中事件。
Am Heart J. 2024 Sep;275:138-140. doi: 10.1016/j.ahj.2024.06.006. Epub 2024 Jun 21.
10
Peripartum cardiomyopathy unveiled: Etiology, diagnosis, and therapeutic insights.围生期心肌病揭秘:病因、诊断和治疗新视角。
Curr Probl Cardiol. 2024 May;49(5):102474. doi: 10.1016/j.cpcardiol.2024.102474. Epub 2024 Feb 22.

引用本文的文献

1
Diagnostic and Therapeutic Challenges Between Peripartum and Influenza-Induced Inflammatory Cardiomyopathy-A Case Report and Literature Review.围产期心肌病与流感诱发的炎症性心肌病之间的诊断和治疗挑战——病例报告及文献综述
J Clin Med. 2025 May 14;14(10):3440. doi: 10.3390/jcm14103440.
2
Hemodynamic Patterns and Left Ventricular Function Recovery in Peripartum Cardiomyopathy: A Comprehensive Echocardiographic Analysis.围产期心肌病的血流动力学模式与左心室功能恢复:一项全面的超声心动图分析
JACC Asia. 2025 Apr;5(4):554-564. doi: 10.1016/j.jacasi.2024.11.019. Epub 2025 Feb 11.
3
An unexpected battle with peripartum cardiomyopathy: a case report.

本文引用的文献

1
Increased Cancer Prevalence in Peripartum Cardiomyopathy.围产期心肌病患者癌症患病率增加。
JACC CardioOncol. 2019 Dec 17;1(2):196-205. doi: 10.1016/j.jaccao.2019.09.008. eCollection 2019 Dec.
2
ERBB4 and Multiple MicroRNAs That Target ERBB4 Participate in Pregnancy-Related Cardiomyopathy.ERBB4 及多个靶向 ERBB4 的 microRNAs 参与妊娠相关性心肌病。
Circ Heart Fail. 2021 Jul;14(7):e006898. doi: 10.1161/CIRCHEARTFAILURE.120.006898. Epub 2021 Jul 12.
3
Proinflammatory TH17 cytokine activation, disease severity and outcomes in peripartum cardiomyopathy.
一场与围产期心肌病的意外之战:病例报告
Future Cardiol. 2025 Mar;21(4):223-227. doi: 10.1080/14796678.2025.2472590. Epub 2025 Feb 28.
4
The triglyceride-to-high-density lipoprotein cholesterol ratio is associated with an increased risk of peripartum cardiomyopathy.甘油三酯与高密度脂蛋白胆固醇的比值与围产期心肌病风险增加相关。
Front Endocrinol (Lausanne). 2024 Nov 19;15:1447791. doi: 10.3389/fendo.2024.1447791. eCollection 2024.
5
Prolactin: structure, receptors, and functions.催乳素:结构、受体与功能
Rev Endocr Metab Disord. 2024 Dec;25(6):953-966. doi: 10.1007/s11154-024-09915-8. Epub 2024 Oct 30.
6
Sex difference in human diseases: mechanistic insights and clinical implications.人类疾病中的性别差异:机制见解与临床意义。
Signal Transduct Target Ther. 2024 Sep 10;9(1):238. doi: 10.1038/s41392-024-01929-7.
7
Peripartum heart failure in Finland: A population-based record linkage study.芬兰的围产期心力衰竭:一项基于人群的记录链接研究。
ESC Heart Fail. 2024 Dec;11(6):4277-4284. doi: 10.1002/ehf2.14996. Epub 2024 Aug 25.
8
Precision medicine in peripartum cardiomyopathy: advancing diagnosis and management through genomic and phenotypic integration.围产期心肌病的精准医学:通过基因组和表型整合推进诊断与管理
Ann Med Surg (Lond). 2024 Jul 1;86(8):4664-4667. doi: 10.1097/MS9.0000000000002329. eCollection 2024 Aug.
9
Connecting the Dots: Exploring the Interplay Between Preeclampsia and Peripartum Cardiomyopathy.连接点:探索子痫前期与围产期心肌病之间的相互作用。
J Pregnancy. 2024 Jun 25;2024:7713590. doi: 10.1155/2024/7713590. eCollection 2024.
10
Cardiovascular complications during delivery hospitalizations in inflammatory bowel disease patients.炎症性肠病患者分娩住院期间的心血管并发症。
Clin Res Cardiol. 2024 Jul 2. doi: 10.1007/s00392-024-02476-5.
围生期心肌病中促炎 TH17 细胞因子的激活、疾病严重程度和结局。
Int J Cardiol. 2021 Sep 15;339:93-98. doi: 10.1016/j.ijcard.2021.06.022. Epub 2021 Jul 3.
4
Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM Registry.围生期心肌病女性患者的高血压病:ESC EORP PPCM 注册研究的新认识。
Eur J Heart Fail. 2021 Dec;23(12):2058-2069. doi: 10.1002/ejhf.2264. Epub 2021 Aug 25.
5
Women with peripartum cardiomyopathy have normal ejection fraction, but abnormal systolic strain, during pregnancy.围产期心肌病患者在妊娠期间射血分数正常,但收缩期应变异常。
ESC Heart Fail. 2021 Aug;8(4):3382-3386. doi: 10.1002/ehf2.13323. Epub 2021 May 4.
6
Genetic and Phenotypic Landscape of Peripartum Cardiomyopathy.围生期心肌病的遗传与表型特征。
Circulation. 2021 May 11;143(19):1852-1862. doi: 10.1161/CIRCULATIONAHA.120.052395. Epub 2021 Apr 20.
7
Neighborhood education status drives racial disparities in clinical outcomes in PPCM.社区教育水平导致 PPCM 临床结局的种族差异。
Am Heart J. 2021 Aug;238:27-32. doi: 10.1016/j.ahj.2021.03.015. Epub 2021 Apr 19.
8
Risk stratification and management of women with cardiomyopathy/heart failure planning pregnancy or presenting during/after pregnancy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy.患有心肌病/心力衰竭的女性在计划妊娠或妊娠期间/之后的风险分层和管理:欧洲心脏病学会心力衰竭协会围产期心肌病研究组的立场声明。
Eur J Heart Fail. 2021 Apr;23(4):527-540. doi: 10.1002/ejhf.2133. Epub 2021 Mar 17.
9
Genetics of Peripartum Cardiomyopathy: Current Knowledge, Future Directions and Clinical Implications.围生期心肌病的遗传学:现有知识、未来方向和临床意义。
Genes (Basel). 2021 Jan 15;12(1):103. doi: 10.3390/genes12010103.
10
Human iPSC-Derived Cardiomyocytes of Peripartum Patients With Cardiomyopathy Reveal Aberrant Regulation of Lipid Metabolism.患有心肌病的围产期患者的人诱导多能干细胞衍生心肌细胞揭示了脂质代谢的异常调节。
Circulation. 2020 Dec 8;142(23):2288-2291. doi: 10.1161/CIRCULATIONAHA.119.044962. Epub 2020 Dec 7.